Effect of fibrate to liver enzyme in the patients with dyslipidemia

Effect of fibrate to liver enzyme in the patients with dyslipidemia - Liver enzyme and fibrate at dyslipidemia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044631

Enrollment

500

Registered

2021-06-24

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosis of dyslipidemia prior to the study

Exclusion criteria

Exclusion criteria: Complicated with malignancy Disagree with registration of the study

Design outcomes

Primary

Measure	Time frame
Liver enzyme after administration of fibrate	—

Countries

Japan

Contacts

Public ContactKeisuke Kakisaka

Iwate medical university Division of Hepatology, Department of Internal Medicine

keikaki@iwate-med.ac.jp0196515111

Outcome results